OliLux

Stanford, United States Founded: 2019 • Age: 7 yrs
Tuberculosis detection dyes are provided by OliLux.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About OliLux

OliLux is a company based in Stanford (United States) founded in 2019. OliLux operates in a competitive market with competitors including NuProbe, Nanosphere, ATDBio, Nirvana Sciences and 3Helix, among others.

  • Headquarter Stanford, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $400 K (USD), Grant

    Mar 18, 2021

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of OliLux

Investors in OliLux

OliLux has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Open Philanthropy.

All
Institutional
Investor Description Founded Year Domain Location
Open Philanthropy is engaged in funding impactful global initiatives.
Locked Locked Locked
Premium access

Investor details for OliLux

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by OliLux

Investments
Premium access

Investment portfolio details for OliLux

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - OliLux

Premium access

Detailed financials for OliLux

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Olilux Comparisons

OliLux Primary company
Description
Tuberculosis detection dyes are provided by OliLux.
Location
Stanford, United States
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for OliLux

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of OliLux

OliLux operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Nanosphere, ATDBio, Nirvana Sciences and 3Helix, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Sensitive multiplex platforms for QPCR are developed using toehold probes.
Locked Locked Locked
Diagnostic tests for personalized medicine targeting infections are provided.
Locked Locked Locked
Developer of oligonucleotides
Locked Locked Locked
Fluorescent dyes are manufactured for medical diagnostic and imaging systems.
Locked Locked Locked
Reagents for binding denatured collagen are developed and offered.
Premium access

Detailed competitors of OliLux

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Olilux

Premium access

Complete news archive for OliLux

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about OliLux

OliLux was founded in 2019 and raised its 1st funding round 2 years after it was founded.

OliLux is headquartered in Stanford, United States. It is registered at Stanford, California, United States.

OliLux was founded in 2019 in Stanford, United States, and operates in the biotechnology sector focused on diagnostics. Solvatochromic trehalose dyes, such as DMN-Trehalose and 3HC-3-Trehalose, are supplied in solution form to identify living mycobacteria by fluorescence upon metabolic reaction with their outer membrane. These dyes target actinobacteria phylum species, distinguishing them from other microbes. Clinical diagnostic tests for tuberculosis are also under development.

OliLux's top competitors include NuProbe, Nanosphere and Nirvana Sciences.

OliLux has 1 investor. Key investors include Open Philanthropy.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available